Early progressive feeding in extremely preterm infants: a randomized trial.
Ariel A Salas, Peng Li, Kelli Parks...
https://pubmed.ncbi.nlm.nih.gov/29529231Actively Recruiting
Led by University of Washington · Updated on 2025-07-28
350
Participants Needed
6
Research Sites
12 weeks
Total Duration
U
University of Washington
Lead Sponsor
U
University of Alabama at Birmingham
Collaborating Sponsor
Researchers are evaluating the best timing to advance enteral feeding in very preterm infants born between 25 and 31 weeks gestation who weigh less than 1500 grams at birth. The study aims to find out if starting to increase milk feeds earlier, after one day of small "trophic" feeds, compared to after three days of trophic feeds, reduces the risk of late-onset sepsis (a serious infection occurring after the first 3 days of life) without causing more complications. This multi-center, randomized controlled trial compares these two feeding strategies to improve survival and health outcomes in these vulnerable newborns. Infants will be randomly assigned to one of two feeding plans: limited trophic feeds for about 24 hours or extended trophic feeds for about 72 hours, both at volumes of 20-25 mL/kg/day. After the assigned trophic feeding period, enteral feeds will be advanced by about 25-30 mL/kg/day until full feeding volumes of 140 mL/kg/day are reached, typically within two weeks. The feeds consist of the infant’s own mother's milk or donor human milk if the mother's milk is unavailable. The study allows adjustments if signs of feeding intolerance occur. Participants will be closely monitored throughout their hospital stay until around 40 weeks corrected gestational age. Researchers will assess the occurrence of culture-proven late-onset sepsis, length of hospital stay, death, use of intravenous nutrition and central lines, and other complications like necrotizing enterocolitis, brain hemorrhages, lung disease, and eye problems. Growth measurements such as weight, length, and head size changes will also be tracked. This thorough monitoring aims to determine the safest and most effective feeding approach for very preterm infants.
CONDITIONS
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - Up to 36 hours after birth
Participants are screened for eligibility to participate in the trial.
1 visit (in-person, consent and enrollment)
Duration - Up to 2 weeks or until full feeding volumes are reached
Participants receive either limited trophic feeding for 24 hours or extended trophic feeding for 72 hours, followed by progressive advancement of enteral feeds until full feeds are reached. Feeding consists of parent's own milk or donor human milk. Intravenous fluids and nutrition are provided as needed until full enteral feeding is established.
Daily clinical care visits during hospitalization
Duration - Up to hospital discharge, approximately 40 weeks' gestation
Participants are monitored for late onset sepsis and other clinical outcomes until discharge from the neonatal intensive care unit, around 40 weeks' gestation.
Ongoing assessments during hospitalization
Total: 6 locations
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
Not Yet Recruiting
2
University of South Florida
Tampa, Florida, United States, 33606
Not Yet Recruiting
3
University of Oklahoma
Oklahoma City, Oklahoma, United States, 73104
Not Yet Recruiting
4
Baylor College of Medicine
Houston, Texas, United States, 77030
Not Yet Recruiting
5
University of Washington
Seattle, Washington, United States, 98195
Not Yet Recruiting
6
St. Joseph's Medical Center
Tacoma, Washington, United States, 98405
Actively Recruiting
G
Gregory C Valentine, MD MED FAAP
A
Ariel Salas, MD, MSPH
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ariel A Salas, Peng Li, Kelli Parks...
https://pubmed.ncbi.nlm.nih.gov/29529231Brennan V Higgins, Rebecca J Baer, Martina A Steurer...
https://pubmed.ncbi.nlm.nih.gov/37689808Krystle M Perez, Katie M Strobel, D Taylor Hendrixson...
https://pubmed.ncbi.nlm.nih.gov/38897828Andreas Ohlin, Louise Björkman Hjalmarsson
https://pubmed.ncbi.nlm.nih.gov/33866330Jeffrey R Singer, Emily G Blosser, Carlene L Zindl...
https://pubmed.ncbi.nlm.nih.gov/31700190Christopher J Stewart, Nicholas D Embleton, Emma C L Marrs...
https://pubmed.ncbi.nlm.nih.gov/28701177Chien-Chung Lee, Ye Feng, Yuan-Ming Yeh...
https://pubmed.ncbi.nlm.nih.gov/34690993Maria Quigley, Nicholas D Embleton, Nicholas Meader...
https://pubmed.ncbi.nlm.nih.gov/39239939Maria Quigley, Nicholas D Embleton, William McGuire
https://pubmed.ncbi.nlm.nih.gov/31322731Maria Quigley, William McGuire
https://pubmed.ncbi.nlm.nih.gov/24752468